Literature DB >> 23975863

Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Steve Searles1, Katherine Gauss, Michelle Wilkison, Teri R Hoyt, Erin Dobrinen, Nicole Meissner.   

Abstract

Although acquired bone marrow failure (BMF) is considered a T cell-mediated autoimmune disease, possible innate immune defects as a cause for systemic immune deviations in response to otherwise innocuous infections have not been extensively explored. In this regard, we recently demonstrated an important role of type I IFNs in protecting hematopoiesis during systemic stress responses to the opportunistic fungal pathogen Pneumocystis in lymphocyte-deficient mice. Mice deficient in both lymphocytes and type I IFN receptor (IFrag(-/-) mice) develop rapidly progressing BMF due to accelerated bone marrow (BM) cell apoptosis associated with innate immune deviations in the BM in response to Pneumocystis lung infection. However, the communication pathway between lung and BM eliciting the induction of BMF in response to this strictly pulmonary infection has been unclear. In this study, we report that absence of an intact type I IFN system during Pneumocystis lung infection not only causes BMF in lymphocyte-deficient mice but also transient BM stress in lymphocyte-competent mice. This is associated with an exuberant systemic IFN-γ response. IFN-γ neutralization prevented Pneumocystis lung infection-induced BM depression in type I IFN receptor-deficient mice and prolonged neutrophil survival time in BM from IFrag(-/-) mice. IL-1β and upstream regulators of IFN-γ, IL-12, and IL-18 were also upregulated in lung and serum of IFrag(-/-) mice. In conjunction, there was exuberant inflammasome-mediated caspase-1 activation in pulmonary innate immune cells required for processing of IL-18 and IL-1β. Thus, absence of type I IFN signaling during Pneumocystis lung infection may result in deregulation of inflammasome-mediated pulmonary immune activation, causing systemic immune deviations triggering BMF in this model.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975863      PMCID: PMC3796383          DOI: 10.4049/jimmunol.1301344

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  110 in total

Review 1.  The pathology of bone marrow failure.

Authors:  Roos J Leguit; Jan G van den Tweel
Journal:  Histopathology       Date:  2010-08-19       Impact factor: 5.087

Review 2.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 3.  The role of type I interferons in the differentiation and function of Th1 and Th2 cells.

Authors:  R de Waal Malefyt
Journal:  Semin Oncol       Date:  1997-06       Impact factor: 4.929

Review 4.  The influence of human immunodeficiency virus-1 on hematopoiesis.

Authors:  A Moses; J Nelson; G C Bagby
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

5.  Systemic dissemination of Pneumocystis carinii in a patient with acquired immunodeficiency syndrome.

Authors:  M B Amin; M P Abrash; E Mezger; G F Sekerak
Journal:  Henry Ford Hosp Med J       Date:  1990

6.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-1993. A 28-year-old man with AIDS, persistent pancytopenia, and lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

7.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

Review 8.  Fungal pathogen recognition by the NLRP3 inflammasome.

Authors:  Sophie Joly; Fayyaz S Sutterwala
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

9.  Autoimmune thyroiditis and myelosuppression following treatment with interferon-alpha for hepatitis C.

Authors:  K Schmitt; B C Hompesch; K Oeland; W G von Staehr; P A Thürmann
Journal:  Int J Clin Pharmacol Ther       Date:  1999-04       Impact factor: 1.366

10.  Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity.

Authors:  J M Yu; R V Emmons; Y Hanazono; S Sellers; N S Young; C E Dunbar
Journal:  Exp Hematol       Date:  1999-05       Impact factor: 3.084

View more
  8 in total

1.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

2.  Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice.

Authors:  Justin R Prigge; Teri R Hoyt; Erin Dobrinen; Mario R Capecchi; Edward E Schmidt; Nicole Meissner
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

3.  Murine models of Pneumocystis infection recapitulate human primary immune disorders.

Authors:  Waleed Elsegeiny; Mingquan Zheng; Taylor Eddens; Richard L Gallo; Guixiang Dai; Giraldina Trevejo-Nunez; Patricia Castillo; Kara Kracinovsky; Hillary Cleveland; William Horne; Jonathan Franks; Derek Pociask; Mark Pilarski; John F Alcorn; Kong Chen; Jay K Kolls
Journal:  JCI Insight       Date:  2018-06-21

4.  B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.

Authors:  Teri R Hoyt; Erin Dobrinen; Irina Kochetkova; Nicole Meissner
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

Review 5.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

6.  Antifungal amphiphilic aminoglycoside K20: bioactivities and mechanism of action.

Authors:  Sanjib K Shrestha; Cheng-Wei T Chang; Nicole Meissner; John Oblad; Jaya P Shrestha; Kevin N Sorensen; Michelle M Grilley; Jon Y Takemoto
Journal:  Front Microbiol       Date:  2014-12-05       Impact factor: 5.640

7.  Effects of Porphyromonas gingivalis LipopolysaccharideTolerized Monocytes on Inflammatory Responses in Neutrophils.

Authors:  Xiang-Qing Zhu; Wei Lu; Yang Chen; Xiao-Fan Cheng; Jia-Ying Qiu; Yan Xu; Ying Sun
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

Review 8.  Pathogenesis of Respiratory Viral and Fungal Coinfections.

Authors:  Fabián Salazar; Elaine Bignell; Gordon D Brown; Peter C Cook; Adilia Warris
Journal:  Clin Microbiol Rev       Date:  2021-11-17       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.